PortfoliosLab logoPortfoliosLab logo
SZK vs. CDC
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

SZK vs. CDC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares UltraShort Consumer Goods (SZK) and VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SZK achieves a -15.03% return, which is significantly lower than CDC's 13.97% return. Over the past 10 years, SZK has underperformed CDC with an annualized return of -16.68%, while CDC has yielded a comparatively higher 10.51% annualized return.


SZK

1D
-3.58%
1M
1.29%
YTD
-15.03%
6M
-14.75%
1Y
-5.00%
3Y*
-5.75%
5Y*
-4.45%
10Y*
-16.68%

CDC

1D
1.02%
1M
0.81%
YTD
13.97%
6M
13.78%
1Y
21.05%
3Y*
12.98%
5Y*
6.51%
10Y*
10.51%
*Multi-year figures are annualized to reflect compound growth (CAGR)

SZK vs. CDC - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
SZK
ProShares UltraShort Consumer Goods
-15.03%3.37%-11.33%-3.10%47.20%-37.78%-58.24%-39.43%33.62%-27.22%
CDC
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
13.97%8.96%14.48%-4.99%-7.86%33.05%12.88%19.64%-5.97%15.77%

Correlation

The correlation between SZK and CDC is -0.64, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.64

Correlation (3Y)
Calculated over the trailing 3-year period

-0.61

Correlation (5Y)
Calculated over the trailing 5-year period

-0.64

Correlation (10Y)
Calculated over the trailing 10-year period

-0.61

Correlation (All Time)
Calculated using the full available price history since Jul 2, 2014

-0.57

The correlation between SZK and CDC has been stable across timeframes, ranging from -0.64 to -0.57 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SZK vs. CDC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SZK
SZK Risk / Return Rank: 77
Overall Rank
SZK Sharpe Ratio Rank: 77
Sharpe Ratio Rank
SZK Sortino Ratio Rank: 77
Sortino Ratio Rank
SZK Omega Ratio Rank: 77
Omega Ratio Rank
SZK Calmar Ratio Rank: 77
Calmar Ratio Rank
SZK Martin Ratio Rank: 77
Martin Ratio Rank

CDC
CDC Risk / Return Rank: 7272
Overall Rank
CDC Sharpe Ratio Rank: 7070
Sharpe Ratio Rank
CDC Sortino Ratio Rank: 7474
Sortino Ratio Rank
CDC Omega Ratio Rank: 6464
Omega Ratio Rank
CDC Calmar Ratio Rank: 7777
Calmar Ratio Rank
CDC Martin Ratio Rank: 7474
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SZK vs. CDC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares UltraShort Consumer Goods (SZK) and VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SZKCDCDifference
Sharpe ratioReturn per unit of total volatility

-2.31

Sortino ratioReturn per unit of downside risk

-3.19

Omega ratioGain probability vs. loss probability

0.99

1.36

-0.37

Calmar ratioReturn relative to maximum drawdown

-0.17

3.73

-3.90

Martin ratioReturn relative to average drawdown

-0.37

13.12

-13.49

SZK vs. CDC - Sharpe Ratio Comparison

The current SZK Sharpe Ratio is -0.19, which is lower than the CDC Sharpe Ratio of 2.12. The chart below compares the historical Sharpe Ratios of SZK and CDC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SZK vs. CDC - Drawdown Comparison

The maximum SZK drawdown since its inception was -99.40%, which is greater than CDC's maximum drawdown of -21.37%. Use the drawdown chart below to compare losses from any high point for SZK and CDC.


Loading charts...

Drawdown Indicators


SZKCDCDifference

Max Drawdown

Largest peak-to-trough decline

-99.40%

-21.37%

-78.03%

Max Drawdown (1Y)

Largest decline over 1 year

-29.26%

-5.67%

-23.59%

Max Drawdown (3Y)

Largest decline over 3 years

-41.81%

-12.70%

-29.11%

Max Drawdown (5Y)

Largest decline over 5 years

-41.81%

-21.37%

-20.44%

Max Drawdown (10Y)

Largest decline over 10 years

-86.78%

-21.37%

-65.41%

Current Drawdown

Current decline from peak

-99.28%

-0.49%

-98.79%

Average Drawdown

Average peak-to-trough decline

-82.02%

-5.09%

-76.93%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.60%

1.61%

+11.99%

Volatility

SZK vs. CDC - Volatility Comparison

ProShares UltraShort Consumer Goods (SZK) has a higher volatility of 10.21% compared to VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) at 3.44%. This indicates that SZK's price experiences larger fluctuations and is considered to be riskier than CDC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SZKCDCDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.21%

3.44%

+6.77%

Volatility (6M)

Calculated over the trailing 6-month period

21.18%

7.13%

+14.05%

Volatility (1Y)

Calculated over the trailing 1-year period

26.03%

9.99%

+16.04%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

31.60%

12.52%

+19.08%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

33.63%

13.21%

+20.42%

SZK vs. CDC - Expense Ratio Comparison

SZK has a 0.95% expense ratio, which is higher than CDC's 0.37% expense ratio.


Dividends

SZK vs. CDC - Dividend Comparison

SZK's dividend yield for the trailing twelve months is around 2.79%, less than CDC's 3.14% yield.


PositionTTM20252024202320222021202020192018201720162015
CDC
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
3.14%3.36%3.32%4.24%3.48%2.65%2.48%3.04%3.37%2.81%2.99%3.17%
SZK
ProShares UltraShort Consumer Goods
2.79%2.90%5.70%4.03%0.56%0.00%0.19%1.70%0.50%0.00%0.00%0.00%

Frequently Asked Questions


SZK and CDC have a correlation of -0.64, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SZK has higher volatility (10.21%) compared to CDC (3.44%). In terms of maximum drawdown, SZK dropped -99.40% vs CDC's -21.37%.

On 10-year performance, CDC leads with 10.51% vs -16.68% for SZK. On fees, CDC is cheaper at 0.37% per year. On volatility, CDC has been the lower-risk option at 3.44%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, CDC has performed better with a 10.51% return vs -16.68%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

CDC is cheaper with a 0.37% expense ratio, compared with 0.95% for SZK.

CDC has the higher dividend yield at 3.14%, compared with 2.79% for SZK.

SZK is categorized as Leveraged Equities, while CDC is Large Cap Value Equities. SZK tracks Dow Jones U.S. Consumer Goods Index (-200%), while CDC tracks Nasdaq Victory U.S. Large Cap High Dividend 100 Long/Cash Volatility Weighted Index. They also come from different issuers: ProShares and Crestview. Their fees differ too: 0.95% for SZK and 0.37% for CDC.

CDC currently has the higher Sharpe Ratio (2.12 vs -0.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SZK and CDC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer